$BRLL Balance Sheet | Understand Stock

$BRLL

$0.49 +$0.34 (226.67%) Close

$BRLL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Jun 30, 2026	Q2 FY2026 As of Mar 31, 2026	Q4 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Mar 31, 2020	Q1 FY2020 As of Dec 31, 2019	Q4 FY2019 As of Sep 30, 2019	Q3 FY2019 As of Jun 30, 2019	Q2 FY2019 As of Mar 31, 2019	Q1 FY2019 As of Dec 31, 2018	Q4 FY2018 As of Sep 30, 2018	Q3 FY2018 As of Jun 30, 2018	Q2 FY2018 As of Mar 31, 2018	Q1 FY2018 As of Dec 31, 2017	Q4 FY2017 As of Sep 30, 2017	Q3 FY2017 As of Jun 30, 2017	Q2 FY2017 As of Mar 31, 2017	Q1 FY2017 As of Dec 31, 2016	Q4 FY2016 As of Sep 30, 2016	Q3 FY2016 As of Jun 30, 2016	Q2 FY2016 As of Mar 31, 2016
Current assets:
Cash and cash equivalents
Due from related party
Prepaid
Cash and cash equivalents
Accounts receivable- net of allowance
Advance- employee
Note receivable-related party
Total current assets
Oil lease - unproved, net
Right to use asset, operating lease, net of amortization-related party
Fixed Assets
Total assets
Current liabilities:
Accounts payable
Bank overdraft
Accounts payable and accrued expenses
Advance from shareholder
Consulting payable- related parties
Convertible note - related party
Convertible notes payable- net of discount of $22,667 and zero respectively
Advances from shareholder
Convertible notes payable- net of discount
Accrued expense - relate parties
Convertible notes - net of unamortized debt discount
Lease liability
Fair value, derivative liability
Notes payable
Operating lease liability, current portion-related party
Advance- related party
Total current liabilities
Note payable
Lease liability
Notes payable- long term
Operating lease liability- related party

Total liabilities
Commitment and Contingencies
Stockholders' deficit:
Preferred stock, $0.001 par value, 5,000,000 authorized, 5,000,000 issued and outstanding
Common stock, $0.001 par value, 2,000,000,000 authorized, 2,144,622 issued and outstanding as of June 30, 2026 and 1,007,122 as of December 31, 2025
Common stock to be issued
Additional paid in capital
Stock subscription receivable
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders' deficit

Total liabilities and stockholders' deficit

Comments